COWEN AND COMPANY, LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 114 filers reported holding RELMADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
COWEN AND COMPANY, LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$223,398
-97.2%
64,011
-70.4%
0.02%
-97.0%
Q3 2022$8,013,000
-60.4%
216,441
-79.7%
0.77%
-60.8%
Q2 2022$20,260,000
-35.5%
1,066,854
-8.4%
1.96%
-35.3%
Q1 2022$31,426,000
+831.4%
1,164,361
+677.4%
3.02%
+888.6%
Q4 2021$3,374,000
-19.4%
149,774
-6.2%
0.31%
+54.5%
Q3 2021$4,184,000
-19.1%
159,633
-7.8%
0.20%
-26.7%
Q2 2021$5,175,000
-12.0%
173,133
+3.7%
0.27%
-33.2%
Q1 2021$5,878,000166,9420.40%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders